S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Teva Pharmaceutical Industries Limited (TEV.F) Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.


Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Phone972 3 914 8171



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive TEV News and Ratings via Email

Sign-up to receive the latest news and ratings for TEV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Teva Pharmaceutical Industries Limited (TEV.F) (FRA:TEV) Frequently Asked Questions

What stocks does MarketBeat like better than Teva Pharmaceutical Industries Limited (TEV.F)?

Wall Street analysts have given Teva Pharmaceutical Industries Limited (TEV.F) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teva Pharmaceutical Industries Limited (TEV.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Teva Pharmaceutical Industries Limited (TEV.F)'s key competitors?

What other stocks do shareholders of Teva Pharmaceutical Industries Limited (TEV.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teva Pharmaceutical Industries Limited (TEV.F) investors own include NVIDIA (NVDA), Alpha Pro Tech (APT), General Electric (GE), Inovio Pharmaceuticals (INO), Pfizer (PFE), Teva Pharmaceutical Industries (TEVA), Tivity Health (TVTY), Advanced Micro Devices (AMD), Abbott Laboratories (ABT) and Amarin (AMRN).

Who are Teva Pharmaceutical Industries Limited (TEV.F)'s key executives?

Teva Pharmaceutical Industries Limited (TEV.F)'s management team includes the following people:
  • Mr. Kare Schultz, Pres, CEO & Director (Age 60, Pay $5.6M)
  • Mr. Eliyahu Sharon Kalif, Exec. VP & CFO (Age 48, Pay $655.76k)
  • Dr. Hafrun Fridriksdottir, Exec. VP of Global R&D (Age 59, Pay $2.48M)
  • Mr. Brendan P. O'Grady, Exec. VP of North America Commercial (Age 54, Pay $1.56M)
  • Mr. Gianfranco Nazzi, Exec. VP of International Markets Commercial (Age 52, Pay $2.15M)
  • Mr. Eric Drapé, Exec. VP of Global Operations (Age 59)
  • Deborah A. Griffin, Sr. VP & Chief Accounting Officer
  • Mr. Kevin C. Mannix, Sr. VP of Investor Relations
  • Mr. David M. Stark, Exec. VP & Chief Legal Officer (Age 52)
  • Ms. Lori Queisser, Sr. VP & Global Compliance Officer

What is Teva Pharmaceutical Industries Limited (TEV.F)'s stock symbol?

Teva Pharmaceutical Industries Limited (TEV.F) trades on the FRA under the ticker symbol "TEV."

What is Teva Pharmaceutical Industries Limited (TEV.F)'s official website?

The official website for Teva Pharmaceutical Industries Limited (TEV.F) is www.tevapharm.com.

How can I contact Teva Pharmaceutical Industries Limited (TEV.F)?

The company can be reached via phone at 972 3 914 8171.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.